Myra Vision enrols first patient in trial of Calibreye glaucoma system

​Myra Vision has enrolled the first patient in the ADAPT clinical trial assessing its Calibreye TGT surgical system in the US, following recent approval of its Investigational Device Exemption by the FDA.

The post Myra Vision enrols first patient in trial of Calibreye glaucoma system appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.